A. A. Alexander, A. Maniar, J. S. Cummings, A. M. Hebbeler, D. H. Schulze et al., Isopentenyl Pyrophosphate-Activated CD56+ ???? T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma, Clinical Cancer Research, vol.14, issue.13, pp.4232-4240, 2008.
DOI : 10.1158/1078-0432.CCR-07-4912

Z. Ali, L. Yan, N. Plagman, A. Reichenberg, M. Hintz et al., ???? T Cell Immune Manipulation during Chronic Phase of Simian HIV Infection Confers Immunological Benefits, The Journal of Immunology, vol.183, issue.8, pp.5407-5417, 2009.
DOI : 10.4049/jimmunol.0901760

K. Argentati, F. Re, S. Serresi, M. G. Tucci, B. Bartozzi et al., Reduced Number and Impaired Function of Circulating ???? T Cells in Patients with Cutaneous Primary Melanoma, Journal of Investigative Dermatology, vol.120, issue.5, pp.829-834, 2003.
DOI : 10.1046/j.1523-1747.2003.12141.x

J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

S. Bauer, V. Groh, J. Wu, A. Steinle, J. H. Phillips et al., Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA, Science, vol.285, issue.5428, pp.727-729, 1999.
DOI : 10.1126/science.285.5428.727

J. Bennouna, E. Bompas, E. M. Neidhardt, F. Rolland, I. Philip et al., Phase-I study of Innacell ???????, an autologous cell-therapy product highly enriched in ??9??2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.99, issue.11, pp.1599-1609, 2008.
DOI : 10.1007/s00262-008-0491-8

I. Benzaid, H. Monkkonen, V. Stresing, E. Bonnelye, J. Green et al., High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote V??9V??2 T-Cell Chemotaxis and Cytotoxicity In Vivo, Cancer Research, vol.71, issue.13, pp.4562-4572, 2011.
DOI : 10.1158/0008-5472.CAN-10-3862

M. Beyer and J. L. Schultze, Regulatory T cells in cancer, Blood, vol.108, issue.3, pp.804-811, 2006.
DOI : 10.1182/blood-2006-02-002774

W. K. Born, C. L. Reardon, and R. L. O-'brien, The function of ???? T cells in innate immunity, Current Opinion in Immunology, vol.18, issue.1, pp.31-38, 2006.
DOI : 10.1016/j.coi.2005.11.007

M. Brandes, K. Willimann, and B. Moser, Professional Antigen-Presentation Function by Human gd T Cells, Science, vol.309, issue.5732, pp.264-268, 2005.
DOI : 10.1126/science.1110267

M. Brandes, K. Willimann, G. Bioley, N. Levy, M. Eberl et al., Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses, Proceedings of the National Academy of Sciences of the United States of America, pp.2307-2312, 2009.
DOI : 10.1073/pnas.0810059106

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650152

M. S. Braza, A. Caraux, T. Rousset, S. Lafaye-de-micheaux, H. Sicard et al., ???? T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes, The Journal of Immunology, vol.184, issue.1, pp.134-140, 2010.
DOI : 10.4049/jimmunol.0901980

M. S. Braza, B. Klein, G. Fiol, and J. F. Rossi, ???? T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody, Haematologica, vol.96, issue.3, pp.400-407, 2011.
DOI : 10.3324/haematol.2010.029520

J. D. Bui, R. Uppaluri, C. S. Hsieh, and R. D. Schreiber, Comparative Analysis of Regulatory and Effector T Cells in Progressively Growing versus Rejecting Tumors of Similar Origins, Cancer Research, vol.66, issue.14, pp.7301-7309, 2006.
DOI : 10.1158/0008-5472.CAN-06-0556

M. Burjanadze, M. Condomines, T. Reme, P. Quittet, P. Latry et al., In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma, British Journal of Haematology, vol.83, issue.2, pp.206-216, 2007.
DOI : 10.1182/blood-2002-12-3665

URL : https://hal.archives-ouvertes.fr/inserm-00169215

F. Cabillic, O. Toutirais, V. Lavoue, C. T. De-la-pintiere, P. Daniel et al., Aminobisphosphonate-pretreated dendritic cells trigger successful V??9V??2 T cell amplification for immunotherapy in advanced cancer patients, Cancer Immunology, Immunotherapy, vol.157, issue.1, pp.1611-1619, 2010.
DOI : 10.1007/s00262-010-0887-0

J. J. Fournie and F. Dieli, Differentiation, phenotype, and function of interleukin-17-pro- ducing human Vgamma9Vdelta2 T cells, Blood, vol.118, pp.129-138, 2011.

R. Casetti, A. Martino, A. Sacchi, C. Agrati, D. Goletti et al., Do human gammadelta T cells respond to M tuberculosis protein antigens? Blood, pp.4776-4777, 2008.

B. Castella, C. Riganti, F. Fiore, F. Pantaleoni, M. E. Canepari et al., Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V??9V??2 T Cells, ???? CD8+ T Cells, Regulatory T Cells, and Dendritic Cells, The Journal of Immunology, vol.187, issue.4, pp.1578-1590, 2011.
DOI : 10.4049/jimmunol.1002514

D. Cendron, S. Ingoure, A. Martino, R. Casetti, F. Horand et al., A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct ???? and ???? T cell responses in primates, European Journal of Immunology, vol.278, issue.2, pp.549-565, 2007.
DOI : 10.1002/eji.200636343

Y. H. Chien and Y. Konigshofer, Antigen recognition by ???? T cells, Immunological Reviews, vol.166, issue.1, pp.46-58, 2007.
DOI : 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y

L. Conti, R. Casetti, M. Cardone, B. Varano, A. Martino et al., Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated ???? T Cells: Role of CD86 and Inflammatory Cytokines, The Journal of Immunology, vol.174, issue.1, pp.252-260, 2005.
DOI : 10.4049/jimmunol.174.1.252

M. Corvaisier, A. Moreau-aubry, E. Diez, J. Bennouna, J. F. Mosnier et al., V??9V??2 T Cell Response to Colon Carcinoma Cells, The Journal of Immunology, vol.175, issue.8, pp.5481-5488, 2005.
DOI : 10.4049/jimmunol.175.8.5481

D. 'asaro, M. , L. Mendola, C. , D. Liberto et al., V??9V??2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells, The Journal of Immunology, vol.184, issue.6, pp.3260-3268, 2010.
DOI : 10.4049/jimmunol.0903454

M. C. Devilder, S. Maillet, I. Bouyge-moreau, E. Donnadieu, M. Bonneville et al., Potentiation of Antigen-Stimulated V??9V??2 T Cell Cytokine Production by Immature Dendritic Cells (DC) and Reciprocal Effect on DC Maturation, The Journal of Immunology, vol.176, issue.3, pp.1386-1393, 2006.
DOI : 10.4049/jimmunol.176.3.1386

F. Dieli, D. Vermijlen, F. Fulfaro, N. Caccamo, S. Meraviglia et al., Targeting Human ???? T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer, Cancer Research, vol.67, issue.15, pp.7450-7457, 2007.
DOI : 10.1158/0008-5472.CAN-07-0199

J. S. Do and B. Min, IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and ???? T cells in vivo, Blood, vol.113, issue.25, pp.6361-6371, 2009.
DOI : 10.1182/blood-2008-12-192997

D. 'ombrain, M. C. Hansen, D. S. Simpson, K. M. Schofield, and L. , ????-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-?? response to Plasmodium falciparum malaria, European Journal of Immunology, vol.159, issue.7, pp.1864-1873, 2007.
DOI : 10.1002/eji.200636889

R. A. Eagle and J. Trowsdale, Promiscuity and the single receptor: NKG2D, Nature Reviews Immunology, vol.201, issue.9, pp.737-744, 2007.
DOI : 10.1038/nri2144

J. D. French, C. L. Roark, W. K. Born, and R. L. O-'brien, ) {gamma}{delta} T cell homeostasis is established in competition with {alpha}{beta} T cells and NK cells, Proceedings of the National Academy of Sciences of the United States of America, pp.14741-14746, 2005.

S. Galluzzo, D. Santini, B. Vincenzi, N. Caccamo, F. Meraviglia et al., Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity, Expert Opinion on Therapeutic Targets, vol.2, issue.7, pp.941-954, 2007.
DOI : 10.1200/JCO.2003.02.122

Q. Gao, S. J. Qiu, J. Fan, J. Zhou, X. Y. Wang et al., Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection, Journal of Clinical Oncology, vol.25, issue.18, pp.2586-2593, 2007.
DOI : 10.1200/JCO.2006.09.4565

J. Gertner-dardenne, C. Bonnafous, C. Bezombes, A. H. Capietto, V. Scaglione et al., Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies, Blood, vol.113, issue.20, pp.4875-4884, 2009.
DOI : 10.1182/blood-2008-08-172296

M. Girardi, Immunosurveillance and Immunoregulation by ???? T Cells, Journal of Investigative Dermatology, vol.126, issue.1, pp.25-31, 2006.
DOI : 10.1038/sj.jid.5700003

H. J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori et al., Human T Cell Receptor ???? Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells, The Journal of Experimental Medicine, vol.263, issue.2, pp.163-168, 2003.
DOI : 10.1038/sj.onc.1203002

V. Groh, A. Steinle, S. Bauer, and T. Spies, Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial T Cells, Science, vol.279, issue.5357, pp.1737-1740, 1998.
DOI : 10.1126/science.279.5357.1737

V. Groh, R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein et al., Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB, Proceedings of the National Academy of Sciences of the United States of America, pp.6879-6884, 1999.

B. Hall, M. Andreeff, and F. Marini, The Participation of Mesenchymal Stem Cells in Tumor Stroma Formation and Their Application as Targeted-Gene Delivery Vehicles, Handbook of Experimental Pharmacology, vol.180, pp.263-283, 2007.
DOI : 10.1007/978-3-540-68976-8_12

S. M. Hayes and R. M. Laird, Genetic Requirements for the Development and Differentiation of lnterleukin-17-Producing ???? T Cells, Critical Reviews??? in Immunology, vol.32, issue.1, pp.81-95, 2012.
DOI : 10.1615/CritRevImmunol.v32.i1.50

T. Henry, G. S. Kirimanjeswara, T. Ruby, J. W. Jones, K. Peng et al., Type I IFN Signaling Constrains IL-17A/F Secretion by ???? T Cells during Bacterial Infections, The Journal of Immunology, vol.184, issue.7, pp.3755-3767
DOI : 10.4049/jimmunol.0902065

N. Himoudi, D. A. Morgenstern, M. Yan, B. Vernay, L. Saraiva et al., Human ???? T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells, The Journal of Immunology, vol.188, issue.4, pp.1708-1716, 2012.
DOI : 10.4049/jimmunol.1102654

S. Hori, T. Nomura, and S. Sakaguchi, Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-1061, 2003.
DOI : 10.1126/science.1079490

F. Iovino, S. Meraviglia, M. Spina, V. Orlando, V. Saladino et al., Immunotherapy targeting colon cancer stem cells, Immunotherapy, vol.3, issue.1, pp.97-106, 2011.
DOI : 10.2217/imt.10.87

H. Jiang and L. Chess, An integrated view of suppressor T cell subsets in immunoregulation, Journal of Clinical Investigation, vol.114, issue.9, pp.1198-1208, 2004.
DOI : 10.1172/JCI23411

N. Kang, J. Zhou, T. Zhang, L. Wang, F. Lu et al., Adoptive immunotherapy of lung cancer with immobilized anti-TCR???? antibody-expanded human ???? T Cells in peripheral blood, Cancer Biology & Therapy, vol.8, issue.16, pp.1540-1549, 2009.
DOI : 10.4161/cbt.8.16.8950

A. E. Karnoub, A. B. Dash, A. P. Vo, A. Sullivan, M. W. Brooks et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.9, issue.7162, pp.557-563, 2007.
DOI : 10.1038/nature06188

H. Kobayashi, Y. Tanaka, J. Yagi, Y. Osaka, H. Nakazawa et al., Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study, Cancer Immunology, Immunotherapy, vol.173, issue.11, pp.469-476, 2007.
DOI : 10.1007/s00262-006-0199-6

H. Kobayashi, Y. Tanaka, J. Yagi, N. Minato, and K. Tanabe, Phase I/II study of adoptive transfer of ???? T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.30, issue.Suppl 1, pp.1075-1084, 2011.
DOI : 10.1007/s00262-011-1021-7

M. Kondo, K. Sakuta, A. Noguchi, N. Ariyoshi, K. Sato et al., Zoledronate facilitates large-scale ex vivo expansion of functional ???? T cells from cancer patients for use in adoptive immunotherapy*, Cytotherapy, vol.10, issue.8, pp.842-856, 2008.
DOI : 10.1080/14653240802419328

Y. Konigshofer and Y. H. Chien, ???? T cells ??? innate immune lymphocytes?, Current Opinion in Immunology, vol.18, issue.5, pp.527-533, 2006.
DOI : 10.1016/j.coi.2006.07.008

V. Kunzmann, E. Bauer, J. Feurle, F. Weissinger, H. P. Tony et al., Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma, Blood, vol.96, pp.384-392, 2000.

V. Kunzmann, B. Kimmel, T. Herrmann, H. Einsele, and M. Wilhelm, regulatory T cells, Immunology, vol.175, issue.2, pp.256-267, 2009.
DOI : 10.1111/j.1365-2567.2008.02894.x

J. Li, M. J. Herold, B. Kimmel, I. Muller, B. Rincon-orozco et al., Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V??9V??2 T Cells, The Journal of Immunology, vol.182, issue.12, pp.8118-8124, 2009.
DOI : 10.4049/jimmunol.0900101

M. Von-lilienfeld-toal, E. Sievers, V. Bodemuller, C. Mihailescu, A. Marten et al., Coculture with dendritic cells promotes proliferation but not cytotoxic activity of ??/?? T cells, Immunology Letters, vol.99, issue.1, pp.103-108, 2005.
DOI : 10.1016/j.imlet.2005.02.001

Z. Liu, B. L. Guo, B. C. Gehrs, L. Nan, and R. D. Lopez, EX VIVO EXPANDED HUMAN V??9V??2+ ????-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITRO, The Journal of Urology, vol.173, issue.5, pp.1552-1556, 2005.
DOI : 10.1097/01.ju.0000154355.45816.0b

Z. Liu, I. E. Eltoum, B. Guo, B. H. Beck, G. A. Cloud et al., Protective Immunosurveillance and Therapeutic Antitumor Activity of ???? T Cells Demonstrated in a Mouse Model of Prostate Cancer, The Journal of Immunology, vol.180, issue.9, pp.6044-6053, 2008.
DOI : 10.4049/jimmunol.180.9.6044

E. Lockhart, A. M. Green, and J. L. Flynn, IL-17 Production Is Dominated by ???? T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection, The Journal of Immunology, vol.177, issue.7, pp.4662-4669, 2006.
DOI : 10.4049/jimmunol.177.7.4662

Y. Ma, L. Aymeric, C. Locher, S. R. Mattarollo, N. F. Delahaye et al., Contribution of IL-17???producing ???? T cells to the efficacy of anticancer chemotherapy, The Journal of Experimental Medicine, vol.178, issue.3, pp.491-503, 2011.
DOI : 10.1016/j.cell.2010.02.015

URL : https://hal.archives-ouvertes.fr/pasteur-00576679

A. Maniar, X. Zhang, W. Lin, B. R. Gastman, C. D. Pauza et al., Human ???? T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement, Blood, vol.116, issue.10, pp.1726-1733, 2010.
DOI : 10.1182/blood-2009-07-234211

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324253

V. Marcu-malina, S. Heijhuurs, M. Van-buuren, L. Hartkamp, S. Strand et al., Redirecting ????T cells against cancer cells by transfer of a broadly tumor-reactive ????T-cell receptor, Blood, vol.118, issue.1, pp.50-59, 2011.
DOI : 10.1182/blood-2010-12-325993

L. Martinet, S. Fleury-cappellesso, M. Gadelorge, G. Dietrich, P. Bourin et al., A regulatory cross-talk between V??9V??2 T lymphocytes and mesenchymal stem cells, European Journal of Immunology, vol.168, issue.3, pp.752-762, 2009.
DOI : 10.1002/eji.200838812

L. Martinet, C. Jean, G. Dietrich, J. J. Fournie, and R. Poupot, PGE2 inhibits natural killer and ???? T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling, Biochemical Pharmacology, vol.80, issue.6, pp.838-845, 2010.
DOI : 10.1016/j.bcp.2010.05.002

S. Meraviglia, M. Eberl, D. Vermijlen, M. Todaro, S. Buccheri et al., In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients, Clinical and Experimental Immunology, vol.161, pp.290-297, 2010.

S. Meuter, M. Eberl, and B. Moser, Prolonged antigen survival and cytosolic export in cross-presenting human ???? T cells, Proceedings of the National Academy of Sciences, vol.107, issue.19, pp.8730-8735, 2010.
DOI : 10.1073/pnas.1002769107

B. Moser and M. Eberl, ???? T cells: novel initiators of adaptive immunity, Immunological Reviews, vol.172, issue.1, pp.89-102, 2007.
DOI : 10.1016/j.immuni.2006.06.002

A. Noguchi, T. Kaneko, T. Kamigaki, K. Fujimoto, M. Ozawa et al., Zoledronate-activated V??9???? T cell-based immunotherapy is feasible and restores the impairment of ???? T cells in patients with solid tumors, Cytotherapy, vol.13, issue.1, pp.92-97, 2011.
DOI : 10.3109/14653249.2010.515581

O. Nussbaumer, G. Gruenbacher, H. Gander, and M. Thurnher, DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by ???? T lymphocytes, Blood, vol.118, issue.10, pp.2743-2751, 2011.
DOI : 10.1182/blood-2011-01-328526

D. Pende, P. Rivera, S. Marcenaro, C. C. Chang, R. Biassoni et al., Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity, Cancer Research, vol.62, pp.6178-6186, 2002.

I. Prigione, F. Benvenuto, P. Bocca, L. Battistini, A. Uccelli et al., Reciprocal Interactions Between Human Mesenchymal Stem Cells and ???? T Cells Or Invariant Natural Killer T Cells, Stem Cells, vol.9, issue.3, pp.693-702, 2009.
DOI : 10.1634/stemcells.2008-0687

G. Qin, Y. Liu, J. Zheng, I. H. Ng, Z. Xiang et al., Type 1 Responses of Human V??9V??2 T Cells to Influenza A Viruses, Journal of Virology, vol.85, issue.19, pp.10109-10116, 2011.
DOI : 10.1128/JVI.05341-11

J. C. Ribot, A. Debarros, D. J. Pang, J. F. Neves, V. Peperzak et al., CD27 is a thymic determinant of the balance between interferon-??- and interleukin 17???producing ???? T cell subsets, Nature Immunology, vol.170, issue.4, pp.427-436, 2009.
DOI : 10.1038/ni.1717

J. C. Ribot, M. Chaves-ferreira, F. Orey, M. Wencker, N. Goncalves-sousa et al., Cutting Edge: Adaptive Versus Innate Receptor Signals Selectively Control the Pool Sizes of Murine IFN-??- or IL-17-Producing ???? T Cells upon Infection, The Journal of Immunology, vol.185, issue.11, pp.6421-6425, 2010.
DOI : 10.4049/jimmunol.1002283

A. J. Roelofs, M. Jauhiainen, H. Monkkonen, M. J. Rogers, J. Monkkonen et al., Peripheral blood monocytes are responsible for ???? T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP, British Journal of Haematology, vol.69, issue.2, pp.245-250, 2009.
DOI : 10.1111/j.1365-2141.2008.07435.x

J. M. Ryan, F. Barry, J. M. Murphy, and B. P. Mahon, Interferon-?? does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clinical & Experimental Immunology, vol.326, issue.2, pp.353-363, 2007.
DOI : 10.1111/j.1365-2249.2007.03422.x

A. Saitoh, M. Narita, N. Watanabe, N. Tochiki, N. Satoh et al., Anti-tumor cytotoxicity of ???? T cells expanded from peripheral blood cells of patients with myeloma and lymphoma, Medical Oncology, vol.328, issue.2, pp.137-147, 2008.
DOI : 10.1007/s12032-007-9004-4

S. Salot, C. Laplace, S. Saiagh, S. Bercegeay, I. Tenaud et al., Large scale expansion of ??9??2 T lymphocytes: Innacell ??????? cell therapy product, Journal of Immunological Methods, vol.326, issue.1-2, pp.63-75, 2007.
DOI : 10.1016/j.jim.2007.07.010

E. Scotet, L. O. Martinez, E. Grant, R. Barbaras, P. Jeno et al., Tumor Recognition following V??9V??2 T Cell Receptor Interactions with a Surface F1-ATPase-Related Structure and Apolipoprotein A-I, Immunity, vol.22, issue.1, pp.71-80, 2005.
DOI : 10.1016/j.immuni.2004.11.012

C. Shi, B. Sahay, J. Q. Russell, K. A. Fortner, N. Hardin et al., Reduced Immune Response to Borrelia burgdorferi in the Absence of ???? T Cells, Infection and Immunity, vol.79, issue.10, pp.3940-3946, 2011.
DOI : 10.1128/IAI.00148-11

H. Sicard, S. Ingoure, B. Luciani, C. Serraz, J. J. Fournie et al., In Vivo Immunomanipulation of V??9V??2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model, The Journal of Immunology, vol.175, issue.8, pp.5471-5480, 2005.
DOI : 10.4049/jimmunol.175.8.5471

D. Simoni, N. Gebbia, F. P. Invidiata, M. Eleopra, P. Marchetti et al., Design, Synthesis, and Biological Evaluation of Novel Aminobisphosphonates Possessing an in Vivo Antitumor Activity Through a ????-T Lymphocytes-Mediated Activation Mechanism, Journal of Medicinal Chemistry, vol.51, issue.21, pp.6800-6807, 2008.
DOI : 10.1021/jm801003y

C. T. Spencer, G. Abate, A. Blazevic, and D. F. Hoft, Only a Subset of Phosphoantigen-Responsive ??9??2 T Cells Mediate Protective Tuberculosis Immunity, The Journal of Immunology, vol.181, issue.7, pp.4471-4484, 2008.
DOI : 10.4049/jimmunol.181.7.4471

C. E. Sutton, S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle et al., Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity, Immunity, pp.31-331, 2009.

A. Takeuchi, T. Dejima, H. Yamada, K. Shibata, R. Nakamura et al., IL-17 production by ???? T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Gu??rin treatment against bladder cancer, European Journal of Immunology, vol.59, issue.1, pp.246-251, 2011.
DOI : 10.1002/eji.201040773

A. Thedrez, C. Sabourin, J. Gertner, M. C. Devilder, S. Allain-maillet et al., Self/non-self discrimination by human ???? T cells: simple solutions for a complex issue?, Immunological Reviews, vol.153, issue.1, pp.123-135, 2007.
DOI : 10.1182/blood-2004-01-0331

A. Thedrez, C. Harly, A. Morice, S. Salot, M. Bonneville et al., IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V??9V??2 T Cells for Adoptive Immunotherapy, The Journal of Immunology, vol.182, issue.6, pp.3423-3431, 2009.
DOI : 10.4049/jimmunol.0803068

K. Thompson, J. Rojas-navea, and M. J. Rogers, Alkylamines cause V??9V??2 T-cell activation and proliferation by inhibiting the mevalonate pathway, Blood, vol.107, issue.2, pp.651-654, 2006.
DOI : 10.1182/blood-2005-03-1025

H. Tokuyama, T. Hagi, S. R. Mattarollo, J. Morley, Q. Wang et al., V??9V??2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs???Rituximab and trastuzumab, International Journal of Cancer, vol.67, issue.11, pp.2526-2534, 2008.
DOI : 10.1002/ijc.23365

E. Viey, G. Fromont, B. Escudier, Y. Morel, S. Da-rocha et al., Phosphostim-Activated ???? T Cells Kill Autologous Metastatic Renal Cell Carcinoma, The Journal of Immunology, vol.174, issue.3, pp.1338-1347, 2005.
DOI : 10.4049/jimmunol.174.3.1338

E. Viey, C. Lucas, F. Romagne, B. Escudier, S. Chouaib et al., Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded V??9V??2 T Cells From Renal Cell Carcinoma Patients, Journal of Immunotherapy, vol.31, issue.3, pp.313-323, 2008.
DOI : 10.1097/CJI.0b013e3181609988

E. Vivier, D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel et al., Innate or Adaptive Immunity? The Example of Natural Killer Cells, Science, vol.331, issue.6013, pp.44-49, 2011.
DOI : 10.1126/science.1198687

URL : https://hal.archives-ouvertes.fr/hal-00611585

M. Wilhelm, V. Kunzmann, S. Eckstein, P. Reimer, F. Weissinger et al., ???? T cells for immune therapy of patients with lymphoid malignancies, Blood, vol.102, issue.1, pp.200-206, 2003.
DOI : 10.1182/blood-2002-12-3665

R. Zhang, X. Zheng, B. Li, H. Wei, and Z. Tian, Human NK Cells Positively Regulate ???? T Cells in Response to Mycobacterium tuberculosis, The Journal of Immunology, vol.176, issue.4, pp.2610-2616, 2006.
DOI : 10.4049/jimmunol.176.4.2610

B. J. Zheng, S. P. Ng, D. T. Chua, J. S. Sham, D. L. Kwong et al., Peripheral ?? T-cell deficit in nasopharyngeal carcinoma, International Journal of Cancer, vol.294, issue.2, pp.213-217, 2002.
DOI : 10.1002/ijc.10326